Clorox news
The WiseView Research desk's stories that name Clorox, the latest headlines about it, and the trades members of Congress and company insiders have disclosed. The CLX page →
- HeadlineIs Clorox's 6% Dividend Yield Safe? The Nov. 2 Earnings Report Could Decide
- HeadlineMacroeconomic Headwinds are Hitting Clorox From All Sides
- HeadlineShould You Forget Clorox Stock Near a 52-Week Low?
- HeadlineClorox (CLX) Earnings Expected to Grow: Should You Buy?
- HeadlineKimberly-Clark vs. Clorox: The Higher Yield May Not Be the Better Dividend
- HeadlineClorox vs. Colgate: One Pays Nearly 6%, but Is It a Dividend Trap?
- HeadlineOctober's 5 Dividend Growth Stocks With Yields Up To 7.99%
- HeadlineClorox Announces November 2 Webcast of First-Quarter Fiscal Year 2027 Results
- HeadlineCalnex and VIAVI expand partnership to deliver end-to-end network and application performance validation for next-generation networks.
- HeadlineColgate vs. Clorox: Which Consumer Staples Giant Holds the Edge?
- HeadlineWall Street's Most Accurate Analysts Spotlight On 3 Defensive Stocks Delivering High-Dividend Yields
- HeadlineWill Innovation and Digital Expansion Efforts Drive Clorox's Growth?
- HeadlineIs the Options Market Predicting a Spike in Clorox Stock?
- CongressGilbert Cisneros sold $1,001 - $15,000 of CLX
- CongressGilbert Cisneros bought $1,001 - $15,000 of CLX
- CongressGilbert Cisneros sold $1,001 - $15,000 of CLX
- CongressRo Khanna bought $1,001 - $15,000 of CLX
- CongressRo Khanna bought $1,001 - $15,000 of CLX
- CongressLisa McClain bought $1,001 - $15,000 of CLX
- CongressJefferson Shreve sold $15,001 - $50,000 of CLX
Headlines link to their publishers. Members of Congress disclose ranges, not exact amounts, and may file weeks after the trade; insider filings are open-market purchases and sales from SEC Form 4. For information only, not investment advice.